Quantcast
Last updated on April 24, 2014 at 16:01 EDT

Latest Anticonvulsants Stories

2013-09-18 08:30:03

MISSISSAUGA, ON, Sept. 18, 2013 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that Health Canada has accepted for review the company's New Drug Submission (NDS) for eslicarbazepine acetate for use as a once-daily adjunctive therapy in the treatment of partial-onset seizures in patients 18 years of age and older with epilepsy. The efficacy and safety of eslicarbazepine acetate as an adjunctive or monotherapy treatment for partial-onset seizures in adults...

2013-09-17 23:33:23

As The Wall Street Journal published on August 22, Dr. Reddy's launched a generic version of Depakote ER with a warning for life-threatening adverse reactions. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) September 17, 2013 AttorneyOne.com, a recognized authority on law, updated the website...

Researchers Use Zebrafish To Reel In New Epilepsy Treatment
2013-09-03 15:36:39

Brett Smith for redOrbit.com - Your Universe Online The phrase ‘thinking outside the box’ has become so common these days, it’s almost thought of as an oxymoronic cliché. However, a group of University of California, San Francisco researchers, doing just that, may have stumbled onto a new drug to treat a certain form of childhood epilepsy. Although previous studies have found antihistamines can make seizures worse, the UCSF researchers found that the antihistamine clemizole can...

Effective Epilepsy Drug Valproate May Cause Birth Defects
2013-08-26 10:47:52

Brett Smith for redOrbit.com - Your Universe Online The anti-seizure drug valproate has been shown to be extremely effective, but a new study has found that it increases the risk of pregnant women giving birth to a child with spina bifida or hypospadias when taken in higher doses. The finding allows for women who suffer from seizures to make a more informed decision when deciding if they want to have a child. "For many women on epilepsy medication, the desire to start a family can be...

2013-08-19 23:22:58

As Businessweek published on August 16, a new lawsuit alleges that Abbott engaged in racketeering when it led an effort to market Depakote for unapproved uses. In light of this news, AttorneyOne, a recognized authority on law, inform that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) August 19, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently...

2013-08-19 16:25:39

Epilepsy Drug Still Not Available to Patients 10 Months After FDA Approval WOODCLIFF LAKE, N.J., Aug. 19, 2013 /PRNewswire/ -- Eisai Inc. filed a petition today with the U.S. Court of Appeals for the District of Columbia asking the court to direct the Drug Enforcement Administration (DEA) to promptly schedule the company's epilepsy drug so that it can make it available to patients. (Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO ) FYCOMPA(TM) (perampanel), a new...

2013-08-15 15:14:58

Women of childbearing age, Asian patients may require alternative medications A study by Johns Hopkins researchers shows that a fifth of U.S. neurologists appear unaware of serious drug safety risks associated with various anti-epilepsy drugs, potentially jeopardizing the health of patients who could be just as effectively treated with safer alternative medications. The findings suggest that the U.S. Food and Drug Administration needs a better way to communicate information to...

2013-08-13 08:30:52

Showed Reduced Fluctuations of Topiramate Steady-State Plasma Concentrations and was Well Tolerated in Healthy Volunteers MAPLE GROVE, Minn., Aug. 13, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc.'s, USL255 (extended-release topiramate), an investigational once-daily formulation for the management of epilepsy, demonstrated equivalent systemic exposure with an improved topiramate (TPM) pharmacokinetic (PK) profile at steady-state, as measured by a significantly lower C(max)...

2013-08-06 23:22:10

The lawyer and consumer rights advocate from the Driscoll Firm, P.C., points to a study cited by the FDA, indicating a connection between pregnant women using migraine headache medications such as Depakote and decreased intelligence in their children. He urges consumers to review the FDA warning and learn more about their legal rights. St. Louis, MO (PRWEB) August 06, 2013 John J. Driscoll, an attorney who represents drug injury victims across the nation, today called consumers’...

2013-07-29 23:25:33

d’Oliveira & Associates is investigating allegations that this drug may be linked to birth defects like cleft lip or palate. The law firm works with Topamax lawyers across the country who are handling these types of lawsuits. (PRWEB) July 29, 2013 Topamax (topiramate) is a drug used to treat epilepsy and prevent migraines. It has also been used for off-label weight loss for many years and recently the FDA approved a combination of topiramate and phentermine for weight loss. In...